June 18, 2013 7:04 PM ET

Capital Markets

Company Overview of Burrill Venture Capital

Company Overview

Burrill Venture Capital is a venture capital and private equity arm of Burrill & Company specializing in startups through mezzanine stage investments. It invests in Series A and B rounds. The firm seeks to invest in life sciences, biotechnology, and healthcare companies with a focus on human healthcare therapeutics; diagnostics and devices; nutraceuticals and wellness; enabling technologies; agricultural biotechnology; biogreentech; cleantechnology, medical technology, and industrial biotechnology including biofuels, biomaterials, and bioprocesses. Within life sciences, it invests in therapeutics, diagnostics, medical devices, healthcare services, biofuels, and digital health. It primarily i...

Detailed Description

One Embarcadero Center

Suite 2700

San Francisco, CA 94111

United States

Founded in 1994

Phone:

415-591-5400

Fax:

415-591-5401

www.burrillandco.com/bio/venture_capital

Key Executives for Burrill Venture Capital

Chief Executive Officer
Age: 67
Managing Director
Age: 59
Managing Director of Burrill-Fosun Fund
Controller
Managing Director
Age: 39
Compensation as of Fiscal Year 2012.

Burrill Venture Capital Key Developments

Burrill & Company Appoints David Wetherell as Managing Director of Burrill Venture Capital Group

Burrill & Company announced that David Wetherell, a veteran entrepreneur and venture capitalist, has joined the Burrill Venture Capital Group as a Managing Director. Along with Wetherell, Douglas Lind, MD, joined the firm as a Managing Director and Joshua Zelig joined as a Director. Wetherell has spent 20 years as a CEO in high-tech, as well as 17 years in venture capital, the last seven of which have been dedicated to biotech and life sciences. Dr. Lind previously served as Managing Director at GBP Capital, a Greenwich, Connecticut-based healthcare venture firm. Dr. Lind previously served as Managing Director at GBP Capital. He has more than 20 years of experience in the life sciences industry, ranging from the practice of clinical medicine to work as a top tier Wall Street equity research analyst and venture capitalist. Zelig was an associate partner at GBP Capital. He was responsible for sourcing, evaluating and executing investment transactions and new business opportunities. Additionally, he managed the firm's intellectual property portfolios, oversaw the company's operations, and worked closely with portfolio companies in setting and delivering on strategic objectives.

Similar Private Companies By Industry

Company Name Region
UBT Management LLC. United States
William K. Woodruff & Company, LLC United States
Montgomery County Teachers Federal Credit Union United States
Trusted Securities Advisors Corp. United States
Allen & Associates, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
March 12, 2013
Flexible Stenting Solutions, Inc.
Private Placement
February 14, 2013
Odyssey Thera, Inc.
Private Placement
February 11, 2013
Strand Life Sciences Private Limited
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Burrill Venture Capital, please visit www.burrillandco.com/bio/venture_capital. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.